Form D — Myris Therapeutics, Inc.
0001924725-26-000004 · filed Oct 14, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,500,000
- Total sold
- $500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Myris Therapeutics, Inc.
- CIK
- 1924725
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 307 23RD ST. EXT
SHARPSBURG, PA 15215 - Phone
- 412-816-5315
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Barbara S. Fox · DirectorSHARPSBURG, PA Find on LinkedIn ↗
-
Laura E. Benjamin · Executive OfficerSHARPSBURG, PA Find on LinkedIn ↗
-
Rebecca Wolfe · Executive OfficerSHARPSBURG, PA Find on LinkedIn ↗
-
Antonina Simakova · Executive OfficerSHARPSBURG, PA Find on LinkedIn ↗
-
Alan Russell · PromoterSHARPSBURG, PA Find on LinkedIn ↗
-
David N. Colaizzi · DirectorSHARPSBURG, PA Find on LinkedIn ↗
-
Krzysztof Matyjaszewski · DirectorSHARPSBURG, PA Find on LinkedIn ↗
-
Mark A. Murcko · DirectorSHARPSBURG, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗